TY  - JOUR
AU  - Martínez-Laperche, Carolina
AU  - Kwon, Mi
AU  - Franco-Villegas, Ana C
AU  - Chillón, M Carmen
AU  - Castro, Nerea
AU  - Anguita, Eduardo
AU  - Dolz, Sandra
AU  - Rodríguez-Medina, Carlos
AU  - Hermosín, Lourdes
AU  - Bellón, José M
AU  - Prieto-Conde, Mª Isabel
AU  - Barragán, Eva
AU  - Gómez-Casares, Maite
AU  - Ayala, Rosa
AU  - Martínez-López, Joaquín
AU  - González-Díaz, Marcos
AU  - Díez-Martin, José Luis
AU  - Buño, Ismael
AU  - Cooperative Group for Molecular Biology in Haematology (GBMH)
PY  - 2017
DO  - 10.1111/bjh.14635
UR  - http://hdl.handle.net/10668/11043
T2  - British journal of haematology
LA  - en
KW  - Wilms Tumor 1
KW  - acute myeloid leukaemia
KW  - chemotherapy
KW  - minimal residual disease
KW  - stem cell transplantation
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Female
KW  - Gene Expression Regulation, Leukemic
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - Risk Assessment
KW  - Risk Factors
KW  - Spain
KW  - WT1 Proteins
TI  - Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.
TY  - research article
VL  - 181
ER  -